NCT01699724View on ClinicalTrials.gov

Bioequivalence Of Zoloft ODT To Jzoloft In Healthy Japanese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Healthy
Interventions
DRUG

JZoloft

50 mg tablet on Day 1 of each period

DRUG

sertraline ODT

50 mg tablet on Day 1 of each period

DRUG

sertraline ODT

50 mg tablet on Day 1 of each period

Trial Locations (1)

Unknown

Pfizer Investigational Site, Hachioji-shi

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT01699724 - Bioequivalence Of Zoloft ODT To Jzoloft In Healthy Japanese Subjects | Biotech Hunter | Biotech Hunter